vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
33.50
-0.22 (-0.65%)
At close: May 28, 2026, 4:00 PM EDT
34.17
+0.67 (2.00%)
After-hours: May 28, 2026, 4:32 PM EDT
vTv Therapeutics Employees
vTv Therapeutics had 26 employees as of December 31, 2025. The number of employees increased by 3 or 13.04% compared to the previous year.
Employees
26
Change (1Y)
3
Growth (1Y)
13.04%
Revenue / Employee
$1,416,885
Profits / Employee
$86,615
Market Cap
415.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 26 | 3 | 13.04% |
| Dec 31, 2024 | 23 | 7 | 43.75% |
| Dec 31, 2023 | 16 | 3 | 23.08% |
| Dec 31, 2022 | 13 | 4 | 44.44% |
| Dec 31, 2021 | 9 | -16 | -64.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Neurogene | 131 |
| Adlai Nortye | 109 |
| C4 Therapeutics | 104 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Zura Bio | 40 |
| Compass Therapeutics | 39 |
VTVT News
- 15 days ago - vTv Therapeutics reports Q1 EPS $1.65, consensus 21c - TheFly
- 15 days ago - vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 20 days ago - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - vTv Therapeutics to Participate in Upcoming May Investor Conferences - GlobeNewsWire
- 2 months ago - vTv Therapeutics to Participate in the 38th Annual ROTH Conference - GlobeNewsWire
- 2 months ago - vTv Therapeutics initiated with an Outperform at Evercore ISI - TheFly
- 2 months ago - vTv Therapeutics price target raised to $55 from $35 at Alliance Global - TheFly
- 2 months ago - vTv Therapeutics reports Q4 EPS (58c), consensus ($1.09) - TheFly